Form 4: Danaher Executive Christopher Paul Riley Reports Stock and Option Grants

Sentiment:

SEC Form 4 Filing


Executive Vice President Christopher Paul Riley reports the acquisition of restricted stock units and employee stock options in Danaher Corp.

Summary

  • Christopher Paul Riley, an Executive Vice President at Danaher Corp, filed a Form 4 with the SEC.
  • The filing reports the grant of 12,034 restricted stock units (RSUs) on March 1, 2025, payable solely in common stock.
  • Riley also received two grants of employee stock options, one for 24,067 shares and another for 34,381 shares, both with an exercise price of $207.76 and expiring on March 1, 2035.
  • Vesting schedules vary for the options, with some vesting in halves on the third and fourth anniversaries of the grant date, and others vesting in quarters over four years.

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. The grants themselves are a positive sign, but not extraordinary.

Positives

  • The grant of RSUs and stock options suggests confidence in Danaher's future performance.
  • The vesting schedules incentivize long-term commitment from the executive.

Future Outlook

The document does not contain explicit forward-looking statements, but the equity grants suggest an expectation of continued growth and profitability at Danaher.

Industry Context

Equity grants are a common practice in publicly traded companies to align executive interests with shareholder value. The size and vesting schedule of these grants are typical for executives at Danaher's level.

Comparison to Industry Standards

  • Danaher's executive compensation practices, including stock options and RSU grants, are generally in line with those of its peers in the industrial and life sciences sectors.
  • Companies like Thermo Fisher Scientific and Agilent Technologies also utilize similar equity-based compensation to incentivize their executives.

Stakeholder Impact

  • The equity grants align the executive's interests with those of shareholders, incentivizing value creation.
  • Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
03/01/2025Date of grant for restricted stock units and employee stock options
03/01/2035Expiration date for employee stock options
03/04/2025Date of signature for the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.